Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1934)
All Articles published online
|
Mar 14, 2007 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Leelawat K, Leelawat S, Narong S, Hongeng S. Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion. World J Gastroenterol 2007; 13(10): 1561-1568 [PMID: 17461449 DOI: 10.3748/wjg.v13.i10.1561] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i10/1561.htm |
| Number | Citing Articles |
| 1 |
Massimiliano Cadamuro, Tommaso Stecca, Simone Brivio, Valeria Mariotti, Romina Fiorotto, Carlo Spirli, Mario Strazzabosco, Luca Fabris. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1435 doi: 10.1016/j.bbadis.2017.07.028
|
| 2 |
Haiquan Sang, Tingting Li, Hangyu Li, Jingang Liu. Gab1 regulates proliferation and migration through the PI3K/Akt signaling pathway in intrahepatic cholangiocarcinoma. Tumor Biology 2015; 36(11): 8367 doi: 10.1007/s13277-015-3590-0
|
| 3 |
CHRISTIAN MAYR, DANIEL NEUREITER, MARTIN PICHLER, FRIEDER BERR, ANDREJ WAGNER, TOBIAS KIESSLICH, KONRAD NAMBERGER. Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine. Molecular Medicine Reports 2015; 12(2): 2247 doi: 10.3892/mmr.2015.3589
|
| 4 |
Tanios Bekaii-Saab, Mitch A. Phelps, Xiaobai Li, Motoyasu Saji, Laura Goff, John Sae Wook Kauh, Bert H. O'Neil, Stephanie Balsom, Catherine Balint, Ryan Liersemann, Vasily V. Vasko, Mark Bloomston, William Marsh, L. Austin Doyle, Gilian Ellison, Michael Grever, Matthew D. Ringel, Miguel A. Villalona-Calero. Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers. Journal of Clinical Oncology 2011; 29(17): 2357 doi: 10.1200/JCO.2010.33.9473
|
| 5 |
Abigail Zabron, Robert J. Edwards, Shahid A. Khan. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Disease Models & Mechanisms 2013; 6(2): 281 doi: 10.1242/dmm.010561
|
| 6 |
Jiaqi Yang, David Sontag, Yuewen Gong, Gerald Y. Minuk. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines. Annals of Hepatology 2021; 21: 100265 doi: 10.1016/j.aohep.2020.09.009
|
| 7 |
Xin-Yu Tan, Shi Chang, Wei Liu, Hui-Huan Tang. Silencing of CXCR4 Inhibits Tumor Cell Proliferation and Neural Invasion in Human Hilar Cholangiocarcinoma. Gut and Liver 2014; 8(2): 196 doi: 10.5009/gnl.2014.8.2.196
|
| 8 |
S.H. Hosseini, F. Sheykhmoun, S. Shahmohamm. Evaluation of Mental Health Status in Caregivers of Patients with Chronic Psychiatric Disorders. Pakistan Journal of Biological Sciences 2010; 13(7): 325 doi: 10.3923/pjbs.2010.325.329
|
| 9 |
Guang Chen, Si-Meng Chen, Xiang Wang, Xiao-Fei Ding, Jian Ding, Ling-Hua Meng. Inhibition of Chemokine (CXC Motif) Ligand 12/Chemokine (CXC Motif) Receptor 4 Axis (CXCL12/CXCR4)-mediated Cell Migration by Targeting Mammalian Target of Rapamycin (mTOR) Pathway in Human Gastric Carcinoma Cells. Journal of Biological Chemistry 2012; 287(15): 12132 doi: 10.1074/jbc.M111.302299
|
| 10 |
KOICHI OKAMOTO, HIDEHIRO TAJIMA, SHINICHI NAKANUMA, SEISHO SAKAI, ISAMU MAKINO, JUN KINOSHITA, HIRONORI HAYASHI, KEISHI NAKAMURA, KATSUNOBU OYAMA, HISATOSHI NAKAGAWARA, HIDETO FUJITA, HIROYUKI TAKAMURA, ITASU NINOMIYA, HIROHISA KITAGAWA, SACHIO FUSHIDA, TAKASHI FUJIMURA, SHINICHI HARADA, TOMOHIKO WAKAYAMA, SHOICHI ISEKI, TETSUO OHTA. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma. International Journal of Oncology 2012; 41(2): 573 doi: 10.3892/ijo.2012.1499
|
| 11 |
Mohammad Amir Mishan, Naghmeh Ahmadiankia, Ahmad Reza Bahrami. CXCR4 and CCR7: Two eligible targets in targeted cancer therapy. Cell Biology International 2016; 40(9): 955 doi: 10.1002/cbin.10631
|
| 12 |
Surang Leelawat, Kawin Leelawat, Siriluck Narong, Oraphan Matangkasombut. The Dual Effects of Δ9-Tetrahydrocannabinol on Cholangiocarcinoma Cells: Anti-Invasion Activity at Low Concentration and Apoptosis Induction at High Concentration. Cancer Investigation 2010; 28(4): 357 doi: 10.1080/07357900903405934
|
| 13 |
Silvia Affo, Le-Xing Yu, Robert F. Schwabe. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer. Annual Review of Pathology: Mechanisms of Disease 2017; 12(1): 153 doi: 10.1146/annurev-pathol-052016-100322
|
| 14 |
KANG SU CHO, SO JUNG YOON, JOO YONG LEE, NAM HOON CHO, YOUNG DEUK CHOI, YUN SEOB SONG, SUNG JOON HONG. Inhibition of tumor growth and histopathological changes following treatment with a chemokine receptor CXCR4 antagonist in a prostate cancer xenograft model. Oncology Letters 2013; 6(4): 933 doi: 10.3892/ol.2013.1515
|
| 15 |
Kawin Leelawat, Wandee Udomchaiprasertkul, Siriluck Narong, Surang Leelawat. Induction of MKP-1 prevents the cytotoxic effects of PI3K inhibition in hilar cholangiocarcinoma cells. Journal of Cancer Research and Clinical Oncology 2010; 136(10): 1537 doi: 10.1007/s00432-010-0811-1
|
| 16 |
YU-XIN LIAO, CHENG-HAO ZHOU, HUI ZENG, DONG-QING ZUO, ZHUO-YING WANG, FEI YIN, YING-QING HUA, ZHENG-DONG CAI. The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review). International Journal of Molecular Medicine 2013; 32(6): 1239 doi: 10.3892/ijmm.2013.1521
|
| 17 |
WEI YANG, XIAOYUAN WANG, WEI ZHENG, KEDONG LI, HAOFENG LIU, YUEMING SUN. Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma. International Journal of Oncology 2013; 42(2): 690 doi: 10.3892/ijo.2012.1741
|
| 18 |
Ning Luo, Dan-dan Chen, Li Liu, Li Li, Zhong-ping Cheng. CXCL12 promotes human ovarian cancer cell invasion through suppressing ARHGAP10 expression. Biochemical and Biophysical Research Communications 2019; 518(3): 416 doi: 10.1016/j.bbrc.2019.07.098
|
| 19 |
KAWIN LEELAWAT, SIRIPORN KEERATICHAMROEN, SURANG LEELAWAT, RUTAIWAN TOHTONG. CD24 induces the invasion of cholangiocarcinoma cells by upregulating CXCR4 and increasing the phosphorylation of ERK1/2. Oncology Letters 2013; 6(5): 1439 doi: 10.3892/ol.2013.1587
|
| 20 |
Simone Brivio, Massimiliano Cadamuro, Luca Fabris, Mario Strazzabosco. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. Gene Expression 2018; 18(1): 31 doi: 10.3727/105221617X15088670121925
|
| 21 |
Mirella Pastore, Giulia Lori, Alessandra Gentilini, Maria Letizia Taddei, Giovanni Di Maira, Claudia Campani, Stefania Recalcati, Pietro Invernizzi, Fabio Marra, Chiara Raggi. Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives. Cells 2020; 9(3): 596 doi: 10.3390/cells9030596
|
| 22 |
Wen-Tao Wang, Hua Ye, Pan-Pan Wei, Bo-Wei Han, Bo He, Zhen- Hua Chen, Yue-Qin Chen. LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner. Journal of Hematology & Oncology 2016; 9(1) doi: 10.1186/s13045-016-0348-0
|
| 23 |
Yang Jiang, Yemei Gao, Xin Li, Fangming He, Yang Liu, Renxian Wang. Caulis Spatholobi extracts inhibit osteosarcoma growth and metastasis through suppression of CXCR4/PI3K/AKT signaling. Journal of Orthopaedic Surgery and Research 2023; 18(1) doi: 10.1186/s13018-023-04437-6
|
| 24 |
M. Fatima Leite, Viviane A. Andrade, Michael H. Nathanson. Signaling Pathways in Liver Diseases. 2010; : 25 doi: 10.1007/978-3-642-00150-5_2
|
| 25 |
Nahid Tamanna, Niaz Mahmood. Emerging Roles of Branched-Chain Amino Acid Supplementation in Human Diseases. International Scholarly Research Notices 2014; 2014: 1 doi: 10.1155/2014/235619
|
| 26 |
Jing Yang, Wenqing Bao, Haiyan Diao, Shaofei Yang, Lin Qiu, Chunjing Xu, Bin Zhao. TRIM29 facilitates proliferation and malignancy of cholangiocarcinoma cells by activating MAPK and β‐catenin pathways. Environmental Toxicology 2023; 38(8): 2002 doi: 10.1002/tox.23826
|
| 27 |
Alphonse E Sirica, Deanna J Campbell, Catherine I Dumur. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma. Current Opinion in Gastroenterology 2011; 27(3): 276 doi: 10.1097/MOG.0b013e32834405c3
|
| 28 |
Lea Duwe, Laura Fouassier, Juan Lafuente-Barquero, Jesper B. Andersen. Unraveling the actin cytoskeleton in the malignant transformation of cholangiocyte biology. Translational Oncology 2022; 26: 101531 doi: 10.1016/j.tranon.2022.101531
|
| 29 |
Gabriel Frampton, Yoshiyuki Ueno, Matthew Quinn, Matthew McMillin, Hae Yong Pae, Cheryl Galindo, Dinorah Leyva-Illades, Sharon DeMorrow. The novel growth factor, progranulin, stimulates mouse cholangiocyte proliferation via sirtuin-1-mediated inactivation of FOXO1. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 303(11): G1202 doi: 10.1152/ajpgi.00104.2012
|
| 30 |
Joseph H. R. Hetmanski, Egor Zindy, Jean-Marc Schwartz, Patrick T. Caswell, Julio Saez-Rodriguez. A MAPK-Driven Feedback Loop Suppresses Rac Activity to Promote RhoA-Driven Cancer Cell Invasion. PLOS Computational Biology 2016; 12(5): e1004909 doi: 10.1371/journal.pcbi.1004909
|
| 31 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3375 doi: 10.1007/978-3-319-26956-6_183
|
| 32 |
Ashraf Mousavi. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy. Immunology Letters 2020; 217: 91 doi: 10.1016/j.imlet.2019.11.007
|
| 33 |
Jingjing Jin, Zhan Zhang, Haowen Wang, Yu Zhan, Gang Li, Han Yang, Zhenghua Fei, Yunsheng Xu, Wenfeng Li. CXCR3 expression in colorectal cancer cells enhanced invasion through preventing CXCR4 internalization. Experimental Cell Research 2018; 371(1): 162 doi: 10.1016/j.yexcr.2018.08.006
|
| 34 |
YU-XIN LIAO, ZE-ZE FU, CHENG-HAO ZHOU, LIAN-CHENG SHAN, ZHUO-YING WANG, FEI YIN, LONG-PO ZHENG, YING-QI HUA, ZHENG-DONG CAI. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments. Oncology Reports 2015; 34(1): 33 doi: 10.3892/or.2015.3992
|
| 35 |
SUMERA I. ILYAS, Gregory J. Gores. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma. Gastroenterology 2013; 145(6): 1215 doi: 10.1053/j.gastro.2013.10.013
|
| 36 |
Bo-Wei Han, Hua Ye, Pan-Pan Wei, Bo He, Cai Han, Zhen-Hua Chen, Yue-Qin Chen, Wen-Tao Wang. Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes. BMC Genomics 2018; 19(1) doi: 10.1186/s12864-018-5133-8
|
| 37 |
T. Grenader, S. Nash, Y. Plotkin, J. Furuse, N. Mizuno, T. Okusaka, H. Wasan, J. Valle, J. Bridgewater. Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies. Annals of Oncology 2015; 26(9): 1910 doi: 10.1093/annonc/mdv253
|
| 38 |
Alessandra Caligiuri, Mirella Pastore, Giulia Lori, Chiara Raggi, Giovanni Di Maira, Fabio Marra, Alessandra Gentilini. Role of Chemokines in the Biology of Cholangiocarcinoma. Cancers 2020; 12(8): 2215 doi: 10.3390/cancers12082215
|
| 39 |
Alphonse E. Sirica. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology 2012; 9(1): 44 doi: 10.1038/nrgastro.2011.222
|
| 40 |
SUTHIDARAK CHAIJAN, SITTIRUK ROYTRAKUL, APIWAT MUTIRANGURA, KAWIN LEELAWAT. Matrigel induces L-plastin expression and promotes L-plastin-dependent invasion in human cholangiocarcinoma cells. Oncology Letters 2014; 8(3): 993 doi: 10.3892/ol.2014.2239
|
| 41 |
Haiquan Sang, Tingting Li, Hangyu Li, Jingang Liu, Kevin D Bunting. Down-Regulation of Gab1 Inhibits Cell Proliferation and Migration in Hilar Cholangiocarcinoma. PLoS ONE 2013; 8(11): e81347 doi: 10.1371/journal.pone.0081347
|
| 42 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_183-1
|
| 43 |
PENPAK MOOLTHIYA, RUTAIWAN TOHTONG, SIRIPORN KEERATICHAMROEN, KAWIN LEELAWAT. Role of mTOR inhibitor in cholangiocarcinoma cell progression. Oncology Letters 2014; 7(3): 854 doi: 10.3892/ol.2014.1799
|
| 44 |
Mahmoud Delphan, Tengda Lin, David B. Liesenfeld, Johanna Nattenmüller, Jürgen T. Böhm, Biljana Gigic, Nina Habermann, Lin Zielske, Petra Schrotz-King, Martin Schneider, Alexis Ulrich, Hans-Ulrich Kauczor, Cornelia M. Ulrich, Jennifer Ose. Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: results from the ColoCare study. Metabolomics 2018; 14(3) doi: 10.1007/s11306-017-1314-8
|
| 45 |
Aashreya Ravichandra, Sonakshi Bhattacharjee, Silvia Affò. Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Advances in Cancer Research 2022; 156: 201 doi: 10.1016/bs.acr.2022.01.009
|
| 46 |
M. Fatima Leite, Mateus T. Guerra, Viviane A. Andrade, Michael H. Nathanson. Signaling Pathways in Liver Diseases. 2015; : 15 doi: 10.1002/9781118663387.ch2
|
| 47 |
Hsing-Ju Wu, Pei-Yi Chu. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. International Journal of Molecular Sciences 2019; 20(17): 4154 doi: 10.3390/ijms20174154
|
| 48 |
Francesca Corti, Federico Nichetti, Alessandra Raimondi, Monica Niger, Natalie Prinzi, Martina Torchio, Elena Tamborini, Federica Perrone, Giancarlo Pruneri, Maria Di Bartolomeo, Filippo de Braud, Sara Pusceddu. Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives. Cancer Treatment Reviews 2019; 72: 45 doi: 10.1016/j.ctrv.2018.11.001
|
| 49 |
Arpit D. Shah, Michael J. Bouchard, Adrian C. Shieh, Matias A Avila. Interstitial Fluid Flow Increases Hepatocellular Carcinoma Cell Invasion through CXCR4/CXCL12 and MEK/ERK Signaling. PLOS ONE 2015; 10(11): e0142337 doi: 10.1371/journal.pone.0142337
|
| 50 |
Chunming Jiang, Xiang Fang, Hongxu Zhang, Xuepeng Wang, Maoqiang Li, Wu Jiang, Fei Tian, Liulong Zhu, Zhenyu Bian. AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells. Biomedicine & Pharmacotherapy 2017; 86: 677 doi: 10.1016/j.biopha.2016.12.055
|